479 related articles for article (PubMed ID: 16242641)
1. Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats.
Cicchetti F; Lapointe N; Roberge-Tremblay A; Saint-Pierre M; Jimenez L; Ficke BW; Gross RE
Neurobiol Dis; 2005 Nov; 20(2):360-71. PubMed ID: 16242641
[TBL] [Abstract][Full Text] [Related]
2. Temporal effects of paraquat/maneb on microglial activation and dopamine neuronal loss in older rats.
Saint-Pierre M; Tremblay ME; Sik A; Gross RE; Cicchetti F
J Neurochem; 2006 Aug; 98(3):760-72. PubMed ID: 16893418
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration.
Mangano EN; Hayley S
Neurobiol Aging; 2009 Sep; 30(9):1361-78. PubMed ID: 18187236
[TBL] [Abstract][Full Text] [Related]
4. Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration.
Purisai MG; McCormack AL; Cumine S; Li J; Isla MZ; Di Monte DA
Neurobiol Dis; 2007 Feb; 25(2):392-400. PubMed ID: 17166727
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of paraquat-induced dopaminergic toxicity on the substantia nigra by (-)-deprenyl in vivo.
Liou HH; Chen RC; Chen TH; Tsai YF; Tsai MC
Toxicol Appl Pharmacol; 2001 Apr; 172(1):37-43. PubMed ID: 11264021
[TBL] [Abstract][Full Text] [Related]
6. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.
Thiruchelvam M; Richfield EK; Baggs RB; Tank AW; Cory-Slechta DA
J Neurosci; 2000 Dec; 20(24):9207-14. PubMed ID: 11124998
[TBL] [Abstract][Full Text] [Related]
7. The impact of combined administration of paraquat and maneb on motor and non-motor functions in the rat.
Tinakoua A; Bouabid S; Faggiani E; De Deurwaerdère P; Lakhdar-Ghazal N; Benazzouz A
Neuroscience; 2015 Dec; 311():118-29. PubMed ID: 26477982
[TBL] [Abstract][Full Text] [Related]
8. Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure.
Barcia C; Sánchez Bahillo A; Fernández-Villalba E; Bautista V; Poza Y Poza M; Fernández-Barreiro A; Hirsch EC; Herrero MT
Glia; 2004 May; 46(4):402-9. PubMed ID: 15095370
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice.
Li X; Matsumoto K; Murakami Y; Tezuka Y; Wu Y; Kadota S
Pharmacol Biochem Behav; 2005 Oct; 82(2):345-52. PubMed ID: 16214209
[TBL] [Abstract][Full Text] [Related]
10. Acute neurotoxic effects of mancozeb and maneb in mesencephalic neuronal cultures are associated with mitochondrial dysfunction.
Domico LM; Zeevalk GD; Bernard LP; Cooper KR
Neurotoxicology; 2006 Sep; 27(5):816-25. PubMed ID: 16889834
[TBL] [Abstract][Full Text] [Related]
11. Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype.
Thiruchelvam M; Richfield EK; Goodman BM; Baggs RB; Cory-Slechta DA
Neurotoxicology; 2002 Oct; 23(4-5):621-33. PubMed ID: 12428734
[TBL] [Abstract][Full Text] [Related]
12. [Effects of co-exposure to paraquat and maneb on system of substantial nigra and striatum in rats].
Xu HY; Chen RR; Cai XY; He DF
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2011 Jan; 29(1):33-8. PubMed ID: 21619794
[TBL] [Abstract][Full Text] [Related]
13. Paraquat and maneb induced neurotoxicity.
Thrash B; Uthayathas S; Karuppagounder SS; Suppiramaniam V; Dhanasekaran M
Proc West Pharmacol Soc; 2007; 50():31-42. PubMed ID: 18605226
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of activating D1 and D2 receptors on electrophysiology of neostriatal neurons in a rat model of Parkinson's disease induced by paraquat and maneb.
Xu H; Chen R; Cai X; He D
Neurosci Res; 2011 Dec; 71(4):411-20. PubMed ID: 21903142
[TBL] [Abstract][Full Text] [Related]
15. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed proteins in striatum of maneb-and paraquat-induced Parkinson's disease phenotype in mouse.
Patel S; Sinha A; Singh MP
Neurotoxicol Teratol; 2007; 29(5):578-85. PubMed ID: 17532186
[TBL] [Abstract][Full Text] [Related]
17. Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies.
Xu L; Sheng J; Tang Z; Wu X; Yu Y; Guo H; Shen Y; Zhou C; Paraoan L; Zhou J
Neurobiol Dis; 2005 Feb; 18(1):152-65. PubMed ID: 15649706
[TBL] [Abstract][Full Text] [Related]
18. A fetal risk factor for Parkinson's disease.
Barlow BK; Richfield EK; Cory-Slechta DA; Thiruchelvam M
Dev Neurosci; 2004; 26(1):11-23. PubMed ID: 15509894
[TBL] [Abstract][Full Text] [Related]
19. Paraquat and Maneb Exposure Alters Rat Neural Stem Cell Proliferation by Inducing Oxidative Stress: New Insights on Pesticide-Induced Neurodevelopmental Toxicity.
Colle D; Farina M; Ceccatelli S; Raciti M
Neurotox Res; 2018 Nov; 34(4):820-833. PubMed ID: 29859004
[TBL] [Abstract][Full Text] [Related]
20. Consequences of developmental exposure to concentrated ambient ultrafine particle air pollution combined with the adult paraquat and maneb model of the Parkinson's disease phenotype in male mice.
Allen JL; Liu X; Weston D; Conrad K; Oberdörster G; Cory-Slechta DA
Neurotoxicology; 2014 Mar; 41():80-8. PubMed ID: 24486957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
